Promotion For Sglt2 Inhibitor Forxiga 5 Mg 10 Mg In Japan
Feb 27 (Reuters) - Ono Pharmaceutical Co Ltd 4528.T: ONO PHARMACEUTICAL CO LTD: ANNOUNCEMENT CONCERNING TRANSFER OF DISTRIBUTION SALES AND TERMINATION OF CO-PROMOTION FOR SGLT2 INHIBITOR FORXIGA 5 MG 10 MG IN JAPAN Source text: ID:nTSna8b86c Further company coverage: 4528.T (Reporting by Tokyo Newsroom) ((+81345201189;))
Recent news on ONO PHARMACEUTICAL
See all newsBrief: Biohaven Enters Strategic Licensing Agreement With Ono Pharma
Ono Pharma Announces An Exclusive License Agreement With Biohaven To Develop And Commercialize Igg Degraders In Japan, South Korea, Taiwan, And Asean
Bristol Myers sues Amgen over proposed Opdivo biosimilar (updated)
Bristol Myers sues Amgen over proposed Opdivo biosimilar
Brief: UK's MHRA Says Vimseltinib Approved For Use In Adults To Treat Tenosynovial Giant Cell Tumours